Diagnostic Approach and Treatment for Bilateral Axillary Lymphadenopathy

Diagnostic Workup Required Before Treatment

The American College of Radiology recommends axillary ultrasound as the primary modality of choice to evaluate node morphology and determine if masses are solid or cystic 3, 4
Diagnostic mammography and/or digital breast tomosynthesis should be performed to evaluate for potential breast primary lesions 4
Ultrasound-guided core needle biopsy or fine-needle aspiration is mandatory for definitive diagnosis, with specificity of 98-100% 4

The American College of Radiology states that non-Hodgkin's lymphoma frequently presents with bilateral nodal involvement and requires definitive diagnosis through biopsy rather than observation 1, 2
Stage with CT chest/abdomen/pelvis or PET/CT after tissue confirmation 4
Treatment involves systemic chemotherapy, immunotherapy, or radiation based on lymphoma subtype—this is determined by hematology/oncology after biopsy results 1
If breast cancer is confirmed, complete breast imaging workup with MRI is indicated, as MRI identifies occult primary lesions in approximately 70% of cases 4
Sentinel lymph node biopsy has replaced axillary lymph node dissection as standard for clinically node-negative patients 3
For patients with 1-2 positive sentinel nodes, sentinel lymph node biopsy alone is non-inferior to complete axillary dissection based on ACOSOG Z0011 trial results 3

Reactive lymphadenopathy from infection is the most common benign etiology according to the American College of Radiology 2
Bilateral reactive adenopathy from autoimmune conditions requires treatment of the underlying systemic disease 2
Silicone adenitis produces characteristic "snowstorm" appearance on ultrasound and can demonstrate FDG uptake mimicking metastatic disease 2
Treatment involves implant removal if symptomatic 2

Never rely on physical examination alone for assessment, as both sensitivity and specificity are limited 4
Do not delay biopsy of suspicious nodes, as early diagnosis significantly impacts treatment planning and prognosis 4
Do not assume benign etiology even though reactive changes are common—bilateral presentation warrants tissue diagnosis to exclude lymphoma 2
FDG uptake on PET/CT does not confirm malignancy, as multiple benign causes exist including infection and silicone adenitis 1, 2